Israel Englander Unity Biotechnology, Inc. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.4 - $4.27 $265,465 - $2.83 Million	663,664 Added 200.43%	994,787 $393,000
Q2 2022 Aug 15, 2022	SELL	$0.56 - $1.29 $235,782 - $543,141	-421,040 Reduced 55.98%	331,123 $187,000
Q1 2022 May 16, 2022	BUY	$0.72 - $1.86 $144,183 - $372,474	200,255 Added 36.28%	752,163 $842,000
Q4 2021 Feb 14, 2022	BUY	$1.3 - $3.17 $146,382 - $356,948	112,602 Added 25.63%	551,908 $806,000
Q3 2021 Nov 15, 2021	SELL	$2.91 - $4.5 $485,198 - $750,307	-166,735 Reduced 27.51%	439,306 $1.32 Million
Q2 2021 Aug 16, 2021	BUY	$4.15 - $6.3 $2.52 Million - $3.82 Million	606,041 New	606,041 $2.81 Million
Q3 2020 Nov 16, 2020	SELL	$2.94 - $12.43 $1.56 Million - $6.61 Million	-532,047 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$5.28 - $9.67 $2.65 Million - $4.85 Million	501,282 Added 1629.39%	532,047 $4.62 Million
Q1 2020 May 14, 2020	SELL	$5.0 - $7.6 $1.84 Million - $2.8 Million	-368,572 Reduced 92.3%	30,765 $178,000
Q4 2019 Feb 14, 2020	BUY	$5.99 - $8.38 $1.12 Million - $1.56 Million	186,671 Added 87.78%	399,337 $2.88 Million
Q3 2019 Nov 14, 2019	BUY	$5.62 - $9.63 $1.04 Million - $1.78 Million	184,958 Added 667.53%	212,666 $1.3 Million
Q2 2019 Aug 15, 2019	SELL	$7.59 - $10.21 $3.58 Million - $4.82 Million	-471,991 Reduced 94.46%	27,708 $263,000
Q2 2019 Aug 14, 2019	BUY	$7.59 - $10.21 $3.14 Million - $4.23 Million	414,277 Added 484.98%	499,699 $1.23 Million
Q1 2019 May 14, 2019	BUY	$7.65 - $16.66 $653,478 - $1.42 Million	85,422 New	85,422 $693,000
Q4 2018 Feb 14, 2019	SELL	$10.76 - $17.25 $440,062 - $705,490	-40,898 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$14.34 - $22.97 $586,477 - $939,427	40,898 New	40,898 $666,000

Others Institutions Holding UBX

# of Institutions

Shares Held

4.41M

Call Options Held

Put Options Held

Empery Asset Management, LP New York, NY

4.41M
Shares

$6.49 Million
10.37% of portfolio

View Full List

About Unity Biotechnology, Inc.

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $20.6M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

More about UBX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account